1. Home
  2. DVAX vs YELP Comparison

DVAX vs YELP Comparison

Compare DVAX & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.50

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$24.41

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DVAX
YELP
Founded
1996
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
DVAX
YELP
Price
$15.50
$24.41
Analyst Decision
Hold
Hold
Analyst Count
5
5
Target Price
$26.50
$31.60
AVG Volume (30 Days)
2.6M
1.1M
Earning Date
02-20-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.30
EPS
N/A
2.25
Revenue
$330,514,000.00
$1,466,918,000.00
Revenue This Year
$24.63
$5.73
Revenue Next Year
$15.85
$2.81
P/E Ratio
N/A
$10.87
Revenue Growth
26.73
5.34
52 Week Low
$9.20
$23.92
52 Week High
$15.73
$41.22

Technical Indicators

Market Signals
Indicator
DVAX
YELP
Relative Strength Index (RSI) 76.15 24.08
Support Level $15.46 $23.92
Resistance Level $15.59 $27.65
Average True Range (ATR) 0.06 0.93
MACD -0.16 -0.41
Stochastic Oscillator 15.22 9.27

Price Performance

Historical Comparison
DVAX
YELP

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

Share on Social Networks: